Gland Pharma Delivers Q1 Earnings Beat On US, Europe Strength; Motilal Oswal Raises Estimates — Check New Target Price

Gland Pharma's adjusted profit increased 47% YoY to Rs 317 crore, aided by operating leverage and healthy growth in key overseas markets, adds the brokerage.